Blog

Longevity Supplements and Aging Biomarkers: Separating Science from Speculation

Unfair Team • March 10, 2026

The longevity supplement market is one of the fastest growing segments of the industry, driven by a simple and powerful idea: aging is a biological process, biological processes can be modulated, and certain molecules might slow or partially reverse aspects of aging at the cellular level.

The idea is not wrong. The problem is the distance between the idea and the evidence. Most longevity supplements are supported by compelling animal data, plausible molecular mechanisms, and almost no rigorous human lifespan data. This creates a landscape where intelligent people spend thousands of dollars annually on protocols that may do something, may do nothing, or may do things we do not yet understand.

This guide walks through the major longevity supplement categories with a framework for evaluating each one honestly: what the compound does at a molecular level, what the animal data shows, what (if anything) the human data shows, and what a reasonable person might decide based on all of it.

The fundamental problem with longevity research

Proving that something extends human lifespan requires following humans for decades and measuring whether they live longer. This kind of trial is essentially impossible to conduct in a controlled setting. You cannot randomize 10,000 people to NMN or placebo at age 40 and wait 50 years for results.

What researchers can do instead:

• Study model organisms. Yeast, worms, flies, and mice have short lifespans, making lifespan extension studies feasible. But mice are not humans, and interventions that extend mouse lifespan by 20% frequently fail to translate.
• Measure biomarkers of aging. Epigenetic clocks, telomere length, senescent cell burden, NAD+ levels, and inflammatory markers serve as proxies for biological aging. Improving a biomarker is not the same as extending lifespan, but it is the best intermediate signal we have.
• Conduct shorter human trials. These can measure safety, bioavailability, and biomarker effects, but they cannot demonstrate lifespan extension directly.

Every longevity supplement claim must be evaluated against this reality. When someone says "X extends lifespan," ask: in what organism, by what measure, and how confident are we that it translates to humans?

The compounds, evaluated honestly

NAD+ precursors: NMN and NR

The mechanism. Nicotinamide adenine dinucleotide (NAD+) is a coenzyme involved in hundreds of metabolic reactions, including energy production, DNA repair, and sirtuin activation. NAD+ levels decline with age. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors that can raise NAD+ levels when supplemented orally.

Animal data. NMN supplementation in mice has shown improvements in insulin sensitivity, mitochondrial function, physical endurance, and markers of vascular aging. Some mouse studies show lifespan extension, though results are inconsistent across strains and dosing protocols.

Human data. Multiple human trials have confirmed that NMN and NR safely raise blood NAD+ levels. Beyond that, the picture is less clear. Some trials show modest improvements in muscle function, insulin sensitivity, or exercise capacity in older adults. Others show no significant benefit. No human trial has demonstrated lifespan extension (nor could any trial of this duration).

A landmark 2024 randomized controlled trial of NMN (NRHI protocol) found increased NAD+ levels but did not find statistically significant improvements in the primary clinical endpoints (physical function metrics in older adults).

Honest assessment. NAD+ precursors reliably raise NAD+ levels. Whether raising NAD+ levels translates to meaningful healthspan or lifespan benefits in humans is unproven. The safety profile is acceptable. The cost is significant ($50-150/month for quality products).

If you take it: 250-500 mg NMN or 300-1,000 mg NR daily. Consider periodic NAD+ level testing (available through some specialty labs) to confirm your levels are actually rising. Evaluate against functional outcomes (energy, exercise capacity) rather than assuming benefit from the mechanism alone.

Resveratrol

The mechanism. Resveratrol is a polyphenol found in red grape skins, red wine, and peanuts. It activates sirtuins (particularly SIRT1), which are involved in DNA repair, metabolic regulation, and stress response. It also has antioxidant and anti-inflammatory properties.

Animal data. The initial excitement came from studies showing that resveratrol extended lifespan in yeast and obese mice. However, subsequent studies in normal-weight mice showed no lifespan extension. The benefit appeared specific to metabolically stressed organisms, suggesting resveratrol may protect against the damage of a poor diet rather than slowing aging itself.

Human data. Human trials show variable results. Some demonstrate improved markers of cardiovascular health (endothelial function, inflammatory markers) at doses of 150-500 mg daily. Others show no benefit. Bioavailability is notoriously poor (extensive first-pass metabolism), which means most ingested resveratrol never reaches target tissues in active form. The microbiome plays a significant role in resveratrol metabolism (see: Gut Microbiome and Supplement Absorption).

Honest assessment. Resveratrol was the poster molecule of the longevity supplement movement for over a decade, driven largely by the work and public advocacy of Harvard geneticist David Sinclair. Sinclair's early research on sirtuins and resveratrol generated enormous excitement, supplement sales, and media coverage. Subsequent research has not replicated the initial promise as consistently, and Sinclair's broader claims about aging reversal have drawn criticism from some researchers in the field. This does not mean resveratrol is worthless, but the trajectory from "miracle molecule" to "modest polyphenol with bioavailability problems" is a useful lesson in how supplement hype cycles work. The evidence has not held up to the initial promise. It is not harmful at standard doses, but the case for taking it as a longevity intervention is substantially weaker than marketing suggests.

If you take it: 150-500 mg daily with a fat-containing meal. Trans-resveratrol is the active isomer. Manage expectations carefully.

Spermidine

The mechanism. Spermidine is a polyamine that induces autophagy, the cellular self-cleaning process that degrades damaged proteins and organelles. Autophagy declines with age, and its decline is associated with accumulation of cellular damage.

Animal data. Spermidine extends lifespan in yeast, worms, flies, and mice. The effect is consistently linked to autophagy induction. This is one of the more robust cross-species findings in longevity research.

Human data. Observational studies (not trials) suggest that higher dietary spermidine intake is associated with reduced cardiovascular mortality and improved cognitive function in aging populations. A small randomized trial in older adults showed improved memory performance with spermidine supplementation. Larger, longer trials are underway.

Honest assessment. Spermidine has the most consistent cross-species lifespan data and a plausible mechanism (autophagy induction) that directly addresses a known hallmark of aging. The human data is early but promising. Of all the longevity compounds, this one has the most coherent scientific narrative, though "coherent narrative" is not the same as "proven benefit."

If you take it: 1-6 mg daily from supplemental sources, or increase dietary intake through wheat germ, aged cheese, mushrooms, and legumes. Wheat germ is the richest common food source.

Fisetin

The mechanism. Fisetin is a flavonoid found in strawberries and other fruits that has shown senolytic properties in laboratory studies, meaning it selectively kills senescent (damaged, non-dividing) cells. Senescent cells accumulate with age and secrete inflammatory molecules (the senescence-associated secretory phenotype, or SASP) that damage surrounding tissue.

Animal data. A widely cited 2018 study in aged mice showed that fisetin reduced senescent cell markers, reduced age-related pathology, and extended median and maximum lifespan. The effect size was notable.

Human data. Clinical trials are underway but results are limited. The Mayo Clinic has conducted early-phase human studies of fisetin as a senolytic (typically using high intermittent doses rather than daily low doses). Published results are preliminary.

Honest assessment. The senolytic concept is scientifically compelling. Clearing damaged cells that poison their neighbors is a logical anti-aging strategy. Whether fisetin achieves this in humans at supplemental doses, and whether the intermittent high-dose protocol (which is what the mouse studies used) translates to the daily low-dose regimen most consumers follow, remains unanswered.

If you take it: The consumer approach (100-500 mg daily) differs substantially from the research protocol (high-dose pulses of 20 mg/kg for 2 consecutive days, repeated monthly). The daily low-dose approach has not been validated. If you choose the intermittent protocol, discuss it with a physician, as high-dose fisetin can interact with medications.

A note on quercetin. Quercetin, a widely available flavonoid supplement, also has senolytic properties and is part of the most studied senolytic combination in human trials: quercetin + dasatinib (a prescription cancer drug), tested at the Mayo Clinic. Quercetin alone is a supplement, dasatinib is not. Whether quercetin alone has meaningful senolytic activity at supplemental doses (500-1,000 mg) without dasatinib is unclear. It may have modest standalone benefits as an anti-inflammatory and antioxidant, but attributing senolytic effects to quercetin supplements alone is a stretch beyond the current evidence.

Rapamycin (and why it matters to this discussion)

Rapamycin is a prescription immunosuppressant that has become the most discussed longevity drug in the biohacking community. It works by inhibiting mTOR, the master growth/nutrient-sensing pathway. In mouse studies, rapamycin has extended lifespan more consistently and more dramatically than any other single intervention.

It is not a supplement. It requires a prescription. It suppresses the immune system. Some longevity physicians prescribe it at low, intermittent doses to healthy patients, but this is an off-label practice with unknown long-term consequences.

Including it here because the rapamycin conversation shapes how people think about OTC longevity supplements. When someone is interested in "anti-aging protocols," they may be reading about rapamycin and seeking supplement alternatives. Understanding that the pharmacological agents are in a different evidence class helps calibrate expectations for everything else on this list.

Coenzyme Q10 (CoQ10)

The mechanism. CoQ10 is essential for mitochondrial electron transport (energy production) and acts as a lipid-soluble antioxidant. Levels decline with age. Statin medications further deplete CoQ10.

Human data. CoQ10 supplementation has the most human data of any "longevity" compound, though most of it focuses on cardiovascular function rather than lifespan. A large trial (Q-SYMBIO) showed reduced cardiovascular events and mortality in heart failure patients taking 300 mg CoQ10 daily. For healthy adults, the evidence is less dramatic but supports mitochondrial function maintenance.

Honest assessment. CoQ10 is a reasonable supplement for people over 40, particularly those on statins or with cardiovascular concerns. It is not the flashiest longevity compound, but it has the most grounded evidence base. The ubiquinol form is better absorbed than ubiquinone.

If you take it: 100-300 mg ubiquinol daily with a fat-containing meal.

Aging biomarkers worth tracking

If you are taking longevity supplements, you need some way to assess whether they are doing anything. These biomarkers provide intermediate signals:

Grip strength and VO2 max deserve special attention. Both are among the strongest predictors of all-cause mortality in aging populations, and both are modifiable through training. No supplement replaces exercise for these metrics.

A framework for deciding what to take

Given the evidence landscape, here is how a reasonable person might approach longevity supplementation:

Non-negotiable foundations (strong evidence, clear benefit):

• Omega-3 (EPA/DHA): cardiovascular, brain, and inflammatory support
• Vitamin D3: immune, bone, and hormonal support (dose based on bloodwork)
• Magnesium: sleep, metabolic, and cardiovascular support
• Creatine: muscle, brain, and energy support
• CoQ10 (especially after 40 or on statins): mitochondrial support

Reasonable additions (moderate evidence, acceptable risk-benefit):

• Spermidine: autophagy induction, consistent cross-species data
• NMN or NR: NAD+ repletion, especially if levels are measurably low

Speculative but not unreasonable (weak human evidence, plausible mechanism):

• Fisetin (intermittent protocol): senolytic potential, early-stage data
• Resveratrol: modest cardiovascular benefit possible, manage expectations

Not recommended without medical supervision:

• Rapamycin: prescription drug, immune suppression risk
• High-dose niacin for longevity: liver risk, better options available

The cost of longevity supplementation

This is a topic most longevity content avoids, but it matters. A modest longevity stack (omega-3, D3, magnesium, creatine, CoQ10) runs $40-80/month. Add NMN and spermidine and you are at $150-250/month. Add fisetin, resveratrol, and biological age testing and the annual cost can exceed $3,000-5,000.

For that same money, you could fund a gym membership, a year of high-quality food, regular bloodwork, and a few sessions with a good functional medicine doctor. The return on investment from those foundational interventions is far more certain than the return from speculative longevity compounds.

This is not an argument against longevity supplements. It is an argument for sequencing. Invest in the proven foundations first. Add speculative compounds only after the basics are covered and only with money you can spend without stress (because financial stress itself accelerates biological aging through cortisol, inflammation, and impaired sleep).

The honest conclusion

We do not yet have a proven supplement protocol for extending human lifespan. We have interesting leads, compelling mechanisms, and an enormous amount of animal data that may or may not translate. The most evidence-backed longevity interventions remain caloric awareness, regular exercise (both cardiovascular and resistance), adequate sleep, stress management, and social connection.

Social connection deserves special emphasis because it is the most under-discussed longevity factor in the biohacking community. The Harvard Study of Adult Development, which has tracked participants for over 85 years, consistently finds that the quality of close relationships is one of the strongest predictors of both lifespan and healthspan. Loneliness and social isolation carry mortality risk comparable to smoking 15 cigarettes a day. No supplement addresses this. No biomarker captures it. But it may matter more than everything else in this article combined.

Supplements can support these foundations. They may provide additional benefit through mechanisms we are beginning to understand. But anyone selling certainty about lifespan extension through supplementation is outrunning the evidence.

The most honest longevity stack is one built on foundations that are proven to work, supplemented by compounds with acceptable safety profiles and plausible mechanisms, evaluated against measurable biomarkers, and adjusted as the evidence evolves.

In Unfair

The platform includes longevity-focused supplement categories with evidence-tier labeling so you can see the quality of evidence behind each recommendation. Biomarker tracking (bloodwork, functional tests) integrates with your stack timeline, allowing you to evaluate whether NAD+ precursors or other interventions are producing measurable changes over the months and years that longevity protocols require. The system is designed for honest long-term evaluation, not short-term hype cycles.

See also: Bloodwork Interpretation for Stack Optimization, Supplement Foundations for Sustainable Results, Evidence-First Supplement Prioritization.

References

This article is for education only. Longevity supplementation does not replace medical care, health screening, or the foundational lifestyle practices (exercise, nutrition, sleep) that have the strongest evidence for extending healthspan.